Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease.

Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease.

Show other versions (1)

BACKGROUND and AIMS: Animal studies suggest that endocannabinoids could contribute to the development of nonalcoholic fatty liver disease (NAFLD). In addition, NAFLD has been shown to be associated with multiple changes in lipid concentrations in liver biopsies. There are no data on splanchnic free...

Full description

Bibliographic Details
Main Authors:	Westerbacka, J, Kotronen, A, Fielding, B, Wahren, J, Hodson, L, Perttilä, J, Seppänen-Laakso, T, Suortti, T, Arola, J, Hultcrantz, R, Castillo, S, Olkkonen, V, Frayn, K, Orešič, M, Yki-Järvinen, H
Format:	Journal article
Language:	English
Published:	2010

Similar Items

Splanchnic balance of free fatty acids, endocannabinoids and lipids in subjects with NAFLD
by: Kotronen, A, et al.
Published: (2010)

Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease
by: Westerbacka, J, et al.
Published: (2010)

Dietary carbohydrates and fats in nonalcoholic fatty liver disease
by: Yki-Järvinen, H, et al.
Published: (2021)

Gut-liver axis in nonalcoholic fatty liver disease (NAFLD)
by: Koo, Yolanda Wei Ling
Published: (2023)

Hepatic connexin 32 associates with nonalcoholic fatty liver disease severity
by: Warren, Andrew, et al.
Published: (2020)

Endothelial-immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease
by: Ng, Chun Yi, et al.
Published: (2022)

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
by: Scorletti, E, et al.
Published: (2014)

Fatty acid metabolism in adipose tissue, muscle and liver in health and disease.
by: Frayn, K, et al.
Published: (2006)

Adiposity, metabolomic biomarkers and risk of nonalcoholic fatty liver disease: a case-cohort study
by: Pang, Y, et al.
Published: (2021)

Representation of splanchnic afferent pathways in the thalamus of the cat
by: McLeod, J
Published: (1956)

Trafficking and partitioning of fatty acids: The transition from fasted to fed state
by: Hodson, L, et al.
Published: (2010)

Trafficking and partitioning of fatty acids: the transition from fasted to fed state
by: Hodson, L, et al.
Published: (2010)

Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative
by: Chan, Wah Kheong, et al.
Published: (2018)

Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids
by: Luukkonen, PK, et al.
Published: (2019)

Factors associated with nonalcoholic fatty liver disease grades detected by ultrasound at a screening center in Klang Valley, Malaysia
by: Khammas, Abdul Sattar Arif, et al.
Published: (2018)

Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor
by: Personnaz, Jean, et al.
Published: (2023)

Lessons on drug development: a literature review of challenges faced in nonalcoholic fatty liver disease (NAFLD) clinical trials
by: Chen, Joel Yeh Siang, et al.
Published: (2023)

Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease
by: Eddowes, P, et al.
Published: (2019)

Hepatic fatty acid partitioning.
by: Hodson, L, et al.
Published: (2011)

Hepatic fatty acid partitioning
by: Hodson, L, et al.
Published: (2011)

Abnormalities in fatty acid storage and delivery in the metabolic syndrome
by: Karpe, F, et al.
Published: (2007)

Fatty acid metabolism in patients with PPARgamma mutations.
by: Tan, G, et al.
Published: (2008)

A common variant in the glucokinase regulatory gene rs780094 and risk of nonalcoholic fatty liver disease: A meta-analysis
by: Zain, Shamsul Mohd, et al.
Published: (2014)

A nonclassical monocyte phenotype in peripheral blood is associated with nonalcoholic fatty liver disease : a report from an EMIL subcohort
by: Wang, Yan, et al.
Published: (2015)

PERBEDAAN SPEKTRAL VENA HEPATIKA ANTARA OVERWEIGHT DAN NORMAL WEIGHT DENGAN MAUPUN TANPA NONALCOHOLIC FATTY LIVER DISEASE
by: , Martina Widayanti, et al.
Published: (2013)

The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state.
by: Hodson, L, et al.
Published: (2007)

Male 11β-HSD1 knockout mice fed trans-fats and fructose are not protected from metabolic syndrome or nonalcoholic fatty liver disease.
by: Larner, D, et al.
Published: (2016)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
by: Savic, D, et al.
Published: (2020)

Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake
by: Hodson, L, et al.
Published: (2008)

Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake.
by: Hodson, L, et al.
Published: (2008)

Orlistat for overweight subjects with nonalcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2009)

Endocannabinoids control spasticity in a multiple sclerosis model.
by: Baker, D, et al.
Published: (2001)

Lipoprotein lipase and the disposition of dietary fatty acids.
by: Fielding, B, et al.
Published: (1998)

Liver fat and lipid oxidation in humans.
by: Kotronen, A, et al.
Published: (2009)

A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis
by: Parafati, M, et al.
Published: (2018)

Production of fatty alcohols from fatty acids /
by: 394629 Voeste, Theodor, et al.

Trans fatty acids /
by: Dijkstra, Albert J., et al.
Published: (2008)

Homogeneously catalysed hydrogenation of unsaturated fatty acids to unsaturated fatty alcohols /
by: 390081 Stouthamer, B., et al.

Endocannabinoids as endothelium-derived hyperpolarizing factors: The end of the road?
by: Garland, C
Published: (1999)

PPARγ modulates long chain fatty acid processing in the intestinal epithelium
by: Duszka, Kalina, et al.
Published: (2018)